BDX · Becton Dickinson & Co · Earnings Call Transcripts & Audio
$177.85
+1.43 (+0.81%)
At close · Sep 11
Market Cap
$48.31B
Shares
272.39M
Becton Dickinson & Co Earnings Call Transcripts
Quarterly earnings calls for Becton Dickinson & Co (BDX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲10.7%
$4.76B
$288.00M
'22 Q4
22-11-10
▼2.8%
$4.59B
$509.00M
'23 Q1
23-02-02
▲1.5%
$4.82B
$460.00M
'23 Q2
23-05-04
▲5.1%
$4.88B
$407.00M
'23 Q3
23-08-03
▲6.8%
$5.09B
$108.00M
'23 Q4
23-11-09
▲2.6%
$4.71B
$281.00M
'24 Q1
24-02-01
▲4.6%
$5.04B
$537.00M
'24 Q2
24-05-02
▲2.3%
$4.99B
$487.00M
'24 Q3
24-08-01
▲6.9%
$5.44B
$400.00M
'24 Q4
24-11-07
▲9.8%
$5.17B
$303.00M
'25 Q1
25-02-05
▼11.2%
$4.48B
$308.00M
'25 Q2
25-05-01
▼5.3%
$4.73B
$574.00M
'25 Q3
25-08-07
▲37.3%
$7.47B
$493.00M
'25 Q4
25-11-06
▲1.6%
$5.25B
$382.00M
'26 Q1
26-02-09
▲5.2%
$4.71B
−$311.00M
'26 Q2
26-05-07
LATEST
▲5.4%
$4.98B
$377.00M
'26 Q3
26-08-06
Earnings call
FY26 · Q3
2026-08-06
Becton Dickinson & Co (BDX) Q3 2026 Earnings Call Transcript
Confident tone
New BD portfolio and growth platforms
Alaris recall and revenue headwind
BD Excellence operational program
Revenue
$4.98B
▲ 5.4% YoY Diluted EPS
$1.37
▼ 31.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-05-07
Becton Dickinson & Co (BDX) Q2 2026 Earnings Call Transcript
Confident tone
Alaris headwind and remediation
Growth platforms scaling
BD Excellence operating system
Revenue
$4.71B
▲ 5.2% YoY Diluted EPS
$-1.11
▼ 203.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-02-09
Becton Dickinson & Co (BDX) Q1 2026 Earnings Call Transcript
Confident tone
Alaris / Connected Medication Management
Growth Platforms
Innovation Pipeline / R&D
Revenue
$5.25B
▲ 1.6% YoY Diluted EPS
$1.05
▲ 28.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-11-06
Becton Dickinson & Co (BDX) Q4 2025 Earnings Call Transcript
Positive tone
New BD Strategy Acceleration
Innovation and R&D Investment
Vaccines and Biosciences Headwinds
Revenue
$7.47B*
▲ 37.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-08-07
Becton Dickinson & Co (BDX) Q3 2025 Earnings Call Transcript
Positive tone
Tariffs and Macro Headwinds
BD Excellence / Margin Expansion
Segment Performance (BDI / APM / BDB / DS)
Revenue
$4.73B
▼ 5.3% YoY Diluted EPS
$2.00
▲ 51.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-05-01
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Transcript
Positive tone
Tariffs and U.S. manufacturing investment
Q2 revenue shortfall and guidance cut
BD Excellence / margin expansion
Revenue
$4.48B
▼ 11.2% YoY Diluted EPS
$1.07
▼ 26.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-02-05
Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Transcript
Confident tone
Biosciences and Diagnostic Solutions separation
China and Biosciences market headwinds
Fiscal 2025 guidance and outlook
Revenue
$5.17B
▲ 9.8% YoY Diluted EPS
$0.82
▲ 8.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-11-07
Becton Dickinson & Co (BDX) Q4 2024 Earnings Call Transcript
Confident tone
FY24 Financial Results
BD Excellence / Margin Expansion
Advanced Patient Monitoring (APM) Integration
Revenue
$5.44B*
▲ 6.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-08-01
Becton Dickinson & Co (BDX) Q3 2024 Earnings Call Transcript
Confident tone
China market and VBP headwinds
Connected medication management / Alaris pump
BD Excellence operating system / margin expansion
Revenue
$4.99B
▲ 2.3% YoY Diluted EPS
$1.32
▲ 23.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-05-02
Becton Dickinson & Co (BDX) Q2 2024 Earnings Call Transcript
Confident tone
BD Alaris return to market
FY 2024 guidance raise and earnings
BD Excellence / simplification / margins
Revenue
$5.04B
▲ 4.6% YoY Diluted EPS
$1.45
▲ 20.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-02-01
Becton Dickinson & Co (BDX) Q1 2024 Earnings Call Transcript
Confident tone
FY 2024 guidance raise
BD 2025 strategy and execution
China anticoagulants and biologics
Revenue
$4.71B
▲ 2.6% YoY Diluted EPS
$0.75
▼ 43.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-11-09
Becton Dickinson & Co (BDX) Q4 2023 Earnings Call Transcript
Revenue
$5.09B*
▲ 6.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-08-03
Becton Dickinson & Co (BDX) Q3 2023 Earnings Call Transcript
Revenue
$4.88B
▲ 5.1% YoY Diluted EPS
$1.07
▲ 15.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-05-04
Becton Dickinson & Co (BDX) Q2 2023 Earnings Call Transcript
Revenue
$4.82B
▲ 1.5% YoY Diluted EPS
$1.20
▲ 2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-02-02
Becton Dickinson & Co (BDX) Q1 2023 Earnings Call Transcript
Revenue
$4.59B
▼ 2.8% YoY Diluted EPS
$1.34
▼ 25.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-11-10
Becton Dickinson & Co (BDX) Q4 2022 Earnings Call Transcript
Revenue
$4.76B*
▲ 10.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-08-04
Becton Dickinson & Co (BDX) Q3 2022 Earnings Call Transcript
Revenue
$4.64B
▲ 0.7% YoY Diluted EPS
$0.93
▼ 31.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-05-05
Becton Dickinson & Co (BDX) Q2 2022 Earnings Call Transcript
Revenue
$4.75B
▼ 3.2% YoY Diluted EPS
$1.18
▲ 59.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-02-03
Becton Dickinson & Co (BDX) Q1 2022 Earnings Call Transcript
Revenue
$4.72B
▼ 11.2% YoY Diluted EPS
$1.79
▼ 30.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-11-04
Becton Dickinson & Co (BDX) Q4 2021 Earnings Call Transcript
Revenue
$4.30B*
▼ 10.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-08-05
Becton Dickinson & Co (BDX) Q3 2021 Earnings Call Transcript
Revenue
$4.61B
▲ 19.5% YoY Diluted EPS
$1.35
▲ 81.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-05-06
Becton Dickinson & Co (BDX) Q2 2021 Earnings Call Transcript
Revenue
$4.91B
▲ 15.4% YoY Diluted EPS
$0.74
▲ 81.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-01-12
Becton Dickinson & Co (BDX) Q1 2021 Earnings Call Transcript
Revenue
$5.32B
▲ 25.8% YoY Diluted EPS
$2.57
▲ 285.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-11-05
Becton Dickinson & Co (BDX) Q4 2020 Earnings Call Transcript
Revenue
$4.78B
▲ 4.4% YoY Diluted EPS
$0.28
▼ 20% YoY Gross margin
46.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-08-06
Becton Dickinson & Co (BDX) Q3 2020 Earnings Call Transcript
Revenue
$3.85B
▼ 11.4% YoY Diluted EPS
$0.74
▼ 35.8% YoY Gross margin
43.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-05-07
Becton Dickinson & Co (BDX) Q2 2020 Earnings Call Transcript
Revenue
$4.25B
▲ 1.4% YoY Diluted EPS
$0.41
Gross margin
40.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-02-06
Becton Dickinson & Co (BDX) Q1 2020 Earnings Call Transcript
Revenue
$4.22B
▲ 1.6% YoY Diluted EPS
$0.67
▼ 57.6% YoY Gross margin
46.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts
CIK
10795
CUSIP
075887109
13F (30d)
393 filings
366 filers
Visit website
Investor relations